Showing results (361-370 of 1,563) with videos related to
Sort By:
Pageof 157
Asia-Pacific Journal of Clinical Oncology|March 21, 2024
Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy - A systematic review and meta-analysisSoe Thiha Maung, Natee Deepan, Pakanat Decharatanachart, et al.Asia-Pacific Journal of Clinical Oncology|May 30, 2025
Treatment Outcomes of Stereotactic Body Radiotherapy for Ground Glass Opacity Nodules and Solid Lung CancerYasushi Hamamoto, Kenji Makita, Hiromitsu Kanzaki, et al.Asia-Pacific Journal of Clinical Oncology|April 17, 2024
eviQ Cancer Treatments Online: Providing evidence-based information to improve cancer patient outcomesJulia V Shingleton, Brooke W Stapleton, Aisling P Kelly, et al.Asia-Pacific Journal of Clinical Oncology|April 17, 2026
Biomarker-Guided Inflammatory Control and Multidimensional Recovery After Abdominoperineal Resection: A Prospective Cohort StudyShengjie Pan, Gang WangAsia-Pacific Journal of Clinical Oncology|June 23, 2018
The changing paradigm of management in melanoma brain metastasesRahul Ladwa, Victoria AtkinsonAsia-Pacific Journal of Clinical Oncology|September 26, 2020
High-dose methotrexate monotherapy for newly diagnosed primary central nervous system lymphoma: 15-year multicenter experienceWan-Soo Yoon, Jae-Sung Park, Young-Il Kim, et al.Asia-Pacific Journal of Clinical Oncology|June 8, 2026
Oncology Inpatient Resuscitation Planning and Long-Term "Rapid Response Call" OutcomesDhanashree Tikhe, Petition Nhira, Megan Kepreotis, et al.Asia-Pacific Journal of Clinical Oncology|January 3, 2013
Necrolytic migratory erythema associated with glucagonoma syndrome diagnosed by ⁶⁸Ga-DOTANOC PET-CTManas K Sahoo, Somesh Gupta, Ishita Singh, et al.Asia-Pacific Journal of Clinical Oncology|June 26, 2026
Ki-67 Dynamics and Biomarker Conversion as Prognostic Factors in Residual Breast CancerÖmer Faruk Elçiçek, Eyyüp Çavdar, Özge Yalıcı, et al.Asia-Pacific Journal of Clinical Oncology|August 8, 2026
Real-World Outcomes of Consolidation Durvalumab After Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Cohort Study From VietnamHau Thi Tran, Kien Hung Do, Huong T T Nguyen, et al.Pageof 157